Tellvest

Companies Economy Mentions Returns Firms & Analysts Pricing About

Loading…

Descriptive analysis built from SEC filings and public earnings transcripts. Not investment advice.

Joshua Raskin (Nephron Research) — Tellvest

Analysts/Joshua Raskin

Joshua Raskin

Nephron Research

Healthcare

Limited coverage. Only 3 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.

Companies

Questions

Challenge RatePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions.

Challenge Trend

Q4 '24Q4 '25

Focus Areas6 topics

Cloud & AI1Innovation & R&D1Demand1Competitive Dynamics1Revenue Growth1Geographic Expansion1

Trends3 quarters

Questions per Quarter

Questions

Challenging

Companies Covered

Question History3 questions

HCAHCA Healthcare3 quarters

2025 Q4

can you speak to your technology agenda and where you think the greatest opportunities are for HCA and specifically interested in areas where you think AI can help

Cloud & AIInnovation & R&DView in transcript →

2025 Q2

Could you provide just a little bit more color on maybe surgery volumes, both on the inpatient and outpatient side?

DemandCompetitive DynamicsView in transcript →

2024 Q4

Could you speak a little bit more to the ASC performance in the quarter? Maybe more specifics on rate versus volume underneath that 5% to 6% revenue growth

Revenue GrowthGeographic ExpansionView in transcript →